Tiger Brokers

US StockDetailed Quotes
Provided by Tiger Trade Technology Pte. Ltd.

Moderna, Inc.

190.01
+1.070.57%
Post-market: 189.64-0.3700-0.19%19:59 EDT
Volume:10.29M
Turnover:1.94B
Market Cap:75.86B
PE:-23.73
High:193.72
Open:190.26
Low:183.28
Close:188.94
52wk High:208.90
52wk Low:22.28
Shares:399.24M
Float Shares:368.05M
Volume Ratio:0.67
T/O Rate:2.80%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-8.0076
EPS(LYR):-7.2600
ROE:-39.00%
ROA:-13.26%
PB:11.22
PE(LYR):-26.17

Loading ...

OverviewCompanyNewsFilings

Flash Heard: Why Healthcare is Partying Like It's Late 2020

Dow Jones
·
Aug 20

U.S. Stocks on the MOVE-Marvell, Pilgrim's Pride, ServiceNow

Reuters
·
Aug 19

Top Midday Stories: Treasury Lifts Buyback Cap on Long-Dated Securities; Moderna, Merck Say Melanoma Vaccine Meets Primary Endpoint in Trial

MT Newswires Live
·
Aug 19

Goldman Sachs Adjusts Price Target on Moderna to $120 From $67, Keeps Neutral Rating

MT Newswires Live
·
Aug 19

Why 2026 is Biotech's Comeback Year

Dow Jones
·
Aug 19

Moderna data bode well for Sellas into imminent readout, says Maxim

TIPRANKS
·
Aug 19

Moderna Moves Back Toward Covid-Era Valuation with Latest mRNA Update

Dow Jones
·
Aug 19

Moderna : RBC Raises Target Price to $130 from $45

THOMSON REUTERS
·
Aug 19

Leerink says cancer vaccine win should sustain Merck momentum into fall

TIPRANKS
·
Aug 19

Moderna Short Sellers Face About $4.8 Bln on Paper Losses on Wednesday After Stock Surges to $159, According to Ortex Estimates

THOMSON REUTERS
·
Aug 19

Moderna Short-Sellers Stare at Record One-Day Loss as Shares Surge on Vaccine Data

Reuters
·
Aug 19

Moderna Shares Extend Gains, up More than 150%

THOMSON REUTERS
·
Aug 19

Moderna's Experimental Vaccine Prevents Cancer Recurrence, in 'historic' Win for Personalized Medicine. Its Stock is Soaring.

Dow Jones
·
Aug 19

LIVE Markets-Wall Street Struggles for a Modest Bounce-Back

Reuters
·
Aug 19

Instant VIEW-Moderna-Merck Melanoma Vaccine Data Boosts Outlook, but Analysts Await Full Results

Reuters
·
Aug 19

Moderna rises 113.6%

TIPRANKS
·
Aug 19

Phase 3 Melanoma Success Strengthens Moderna’s Oncology Outlook, But Risk‑Reward Keeps Analyst at Hold

TIPRANKS
·
Aug 19

Early notable gainers among liquid option names on August 19th

TIPRANKS
·
Aug 19

Moderna’s Gain Widens To 150%, MRK Rises More Than 12%, BioNTech Climbs Over 24%

Tiger Newspress
·
Aug 19

Analysts Conflicted on These Healthcare Names: Amylyx Pharmaceuticals Inc (AMLX), Moderna (MRNA) and Merck & Company (MRK)

TIPRANKS
·
Aug 19
More